Thrombolex Inc.

Thrombolex Inc. Founded in 2016, Thrombolex, Inc. is engaged in the design, development, manufacture and distribution of innovative endovascular catheters.

The SCAI 2026 Scientific Sessions begin today in Montréal, Canada.Join Thrombolex at Booth 720 to connect with the Inter...
04/23/2026

The SCAI 2026 Scientific Sessions begin today in Montréal, Canada.

Join Thrombolex at Booth 720 to connect with the Interventional Cardiology community and learn more about pulmonary embolism intervention using the BASHIR® Endovascular Device and targeted pharmaco-mechanical lysis (PML).

Thrombolex.com

Thrombolex is proud to support the SCAI Workshop on the Treatment of Pulmonary Embolism: PERT Frameworks, Guideline Upda...
04/22/2026

Thrombolex is proud to support the SCAI Workshop on the Treatment of Pulmonary Embolism: PERT Frameworks, Guideline Updates, and Procedural Skills.

Join us tomorrow at the Hands-on Learning Lab with Endovascular PE Devices. Connect with our team and get hands-on experience with the BASHIR® Endovascular Device and targeted pharmaco-mechanical lysis (PML) in PE intervention.

Thrombolex.com

In PE treatment, delivery makes the difference.The BASHIR® Endovascular Device is designed to mechanically fragment the ...
04/21/2026

In PE treatment, delivery makes the difference.

The BASHIR® Endovascular Device is designed to mechanically fragment the clot while delivering thrombolytics in a targeted manner, helping clinicians balance effectiveness with controlled exposure.

Thrombolex.com

The RAPID-PE Study evaluates the on-the-table protocol using pharmaco-mechanical lysis (PML) with the BASHIR® Endovascul...
04/18/2026

The RAPID-PE Study evaluates the on-the-table protocol using pharmaco-mechanical lysis (PML) with the BASHIR® Endovascular Catheter. This post-market study focuses on safety, feasibility, and effectiveness in clinical practice, supporting confidence in targeted PE treatment.

Visit our website to learn more about the RAPID-PE study.

Thrombolex.com

Thrombolex will be attending the SCAI 2026 Scientific Sessions. We look forward to connecting with the interventional ca...
04/17/2026

Thrombolex will be attending the SCAI 2026 Scientific Sessions. We look forward to connecting with the interventional cardiology community and continuing conversations around pulmonary embolism intervention, targeted thrombolytic delivery, and procedural approaches that support clinical confidence in PE care.

Thrombolex.com

Thank you to the Society of Interventional Radiology and the entire IR community for another outstanding SIR Annual Scie...
04/16/2026

Thank you to the Society of Interventional Radiology and the entire IR community for another outstanding SIR Annual Scientific Meeting.

It was a pleasure connecting and continuing important conversations around targeted PE intervention and procedural innovation.

Thrombolex.com

Control is essential in PE treatment. The BASHIR® Endovascular Catheter combines mechanical clot fragmentation with targ...
04/14/2026

Control is essential in PE treatment.

The BASHIR® Endovascular Catheter combines mechanical clot fragmentation with targeted thrombolytic delivery to give clinicians greater control during intervention.

This balanced approach supports efficient flow restoration while maintaining procedural consistency and safety.

Thrombolex.com

Precision matters in pulmonary embolism treatment.The BASHIR® Endovascular Device integrates mechanical clot fragmentati...
04/12/2026

Precision matters in pulmonary embolism treatment.

The BASHIR® Endovascular Device integrates mechanical clot fragmentation with targeted thrombolytic delivery to give clinicians greater control during PE intervention. This balanced approach supports efficient flow restoration while maintaining procedural safety and consistency.

Thrombolex.com

Thrombolex is live at the SIR Annual Scientific Meeting, connecting with clinicians and discussing procedural approaches...
04/11/2026

Thrombolex is live at the SIR Annual Scientific Meeting, connecting with clinicians and discussing procedural approaches that support controlled, targeted treatment in pulmonary embolism intervention.

Stop by our booth to learn more about the BASHIR® Family of Endovascular Catheters and how integrated mechanical clot engagement with targeted, low-dose thrombolytic delivery supports PE treatment.

Thrombolex.com

The SIR 2026 Annual Scientific Meeting begins tomorrow at the Metro Toronto Convention Centre in Toronto, Canada.Join Th...
04/10/2026

The SIR 2026 Annual Scientific Meeting begins tomorrow at the Metro Toronto Convention Centre in Toronto, Canada.

Join Thrombolex at Booth #1204 from April 11–15 to connect with the interventional radiology community and learn more about targeted PE intervention using the BASHIR® Endovascular Device.

Thrombolex.com

Thrombolex will be attending the Society of Interventional Radiology Annual Scientific Meeting. We look forward to conne...
04/07/2026

Thrombolex will be attending the Society of Interventional Radiology Annual Scientific Meeting. We look forward to connecting with the interventional radiology community and continuing conversations around targeted PE treatment and procedural approaches that support precision and clinical confidence in patient care.

Thrombolex.com

Happy Easter from Thrombolex.Thrombolex.com
04/05/2026

Happy Easter from Thrombolex.

Thrombolex.com

Address

75 Britain Drive
New Britain, PA
18901​

Alerts

Be the first to know and let us send you an email when Thrombolex Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Thrombolex Inc.:

Share